ArticleAmerican journal of cancer research2018

The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities.

Wan-Ting Hu et al.PubMed ↗Full text ↗

No numbers read from the abstract.